PHLAX Mutual Fund

NAV$39.20
Showing 10 of 51 holdings(as of Feb 27, 2026)Top 10 Weight: 55.32%
#TickerNameWeightSharesMkt ValueShare ChgPROSectorPROIndustryPRO
1LLYEli Lilly And Company16.77%232,558$244.65M-5.8KHealth CarePharmaceuticals
2-New Jersey Transportation Trust Fund Authority 5 2027-12-157.72%112,597,989$112.60M-OtherOther
3MRKMerck & Co. Inc.6.02%708,913$87.78MProProPro
4GILDGilead Sciences Inc4.37%427,773$63.72MProProPro
5UNHUnited Health Group4.31%214,171$62.81MProProPro
6VRTXVertex Pharmaceuticals Inc3.56%104,411$51.87MProProPro
7CVSCvs Health Corp3.27%597,350$47.73MProProPro
8LONN:SMLonza Group Ag3.13%65,672$45.68MProProPro
9ARGXArgenx NV ADR3.10%59,035$45.28MProProPro
10REGNRegeneron Pharmaceuticals, Inc.3.07%57,331$44.81MProProPro
See the other 41 holdings of PHLAX
Every position with sector, industry and share changes, as reported Feb 27, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

Top Holdings Themes

PharmaceuticalsBiotechnologyLife Sciences ToolsSemiconductorsAging PopulationImmunologyOncologyHealth InsuranceManaged CareDigital HealthHealth & WellnessBiotechnology Tools

PHLAX Mutual Fund Top Holdings

PHLAX holdings top 10 positions. The top 10 holdings account for 55.3% of the fund, led by Eli Lilly And Company at 16.8%, New Jersey Transportation Trust Fund Authority 5 2027-12-15 at 7.7%, Merck & Co. Inc. at 6.0%.

PHLAX portfolio concentration is relatively high, with the top 10 representing 55.3% of total assets. The largest sector exposure is Health Care at 80.9%.

PHLAX sector allocation provides a detailed breakdown. PHLAX overlap tool shows how holdings compare to other funds in your portfolio.